The use of scopolamine for the estimation of the central antiacetylcholine properties of neuroleptics.
D000109:Acetylcholine / Q000037:antagonists & inhibitors*; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D008032:Limbic System / Q000378:metabolism; D012601:Scopolamine; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D014150:Antipsychotic Agents; D004295:Dihydroxyphenylalanine; D012601:Scopolamine; D014446:Tyrosine 3-Monooxygenase; D000109:Acetylcholine